Key Takeaways
Treatment for alcoholism works. That answer comes first because the data so often gets buried under shame and bad information. Alcohol use disorder (AUD) is a treatable medical condition, and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is direct about it: no matter how severe the problem seems, behavioral therapy, mutual-support groups, and medication can help a person reach and hold onto recovery.
Most care draws on three approaches: FDA-approved medications, counseling, and peer support. Some people use one, though many use all three, layered over time as needs change.
Alcoholism treatment is medical and behavioral care that helps a person stop or reduce drinking and stay in recovery. It runs along a spectrum, from a single conversation with a clinician to weeks in a residential program, and the right point on that spectrum depends on how severe the disorder is and what a person’s life can support.
“Alcoholism” is the everyday word. Clinicians use alcohol use disorder. The 2024 National Survey on Drug Use and Health counted about 28 million people ages 12 and older with AUD in the past year, roughly 1 in 10 of that age group, according to NIAAA’s analysis of that survey. A treatable condition, not a character flaw.
The NIAAA organizes treatment into three options: FDA-approved medications, behavioral treatments (counseling or talk therapy), and mutual-support groups. They aren’t a ranked menu where you pick the best one. They layer. A common path moves through medical detox if it’s needed, then a structured program, then ongoing outpatient care and peer support, with medication running alongside whenever it fits.
AUD also isn’t “curable” in the sense of a problem that vanishes and never returns. It’s a chronic condition, managed over time, the way high blood pressure or asthma is managed. People recover, and the NIAAA’s Alcohol Treatment Navigator exists precisely because the evidence on that is strong.
A clinician diagnoses AUD using the criteria in the DSM-5, the standard diagnostic manual in U.S. mental health care. The diagnosis matters because it shapes the plan. Mild looks different from severe, and the recommended level of care follows from where a person lands.
There are 11 criteria, assessed over a 12-month period. They cover the patterns most people already half-recognize in themselves or someone they love:
Screening tools come first for a lot of people. The AUDIT and the CAGE questionnaire are short, validated checks a primary-care doctor can run in minutes. They don’t diagnose on their own. They flag whether a fuller assessment is worth doing.
Severity ultimately comes down to a count. Meeting two or three of the 11 criteria within a year results in a mild AUD diagnosis, while four or five indicates a moderate case, and six or more points to severe. The NIAAA spells out those exact thresholds in its overview of alcohol use disorder.
That number does real work. It points toward a starting level of care, which is why the table below pairs each tier with the kind of treatment it usually calls for. The match isn’t rigid. A person with moderate AUD and a chaotic home life might still need residential care, and the assessment accounts for that.
| Severity | Criteria Met (of 11) | Typical Starting Point |
|---|---|---|
| Mild | 2–3 | Outpatient counseling, often with medication |
| Moderate | 4–5 | Intensive outpatient or partial hospitalization |
| Severe | 6 or more | Medical detox, then residential or intensive outpatient |
Alcohol rehab isn’t one thing. It’s a continuum, and the American Society of Addiction Medicine (ASAM) built the framework most programs use to place people along it. Detox sits at one end. Standard outpatient and aftercare sit at the other. In between are residential care, partial hospitalization, and intensive outpatient.
The point of the continuum is matching. More intensive care for higher severity and less stable circumstances; less intensive care as a person stabilizes. People also move between levels, usually stepping down. Someone might finish detox, move into a residential program, then transition to intensive outpatient while living at home. The table below shows the levels at a glance.
| Level | What It Involves | Who It Tends to Fit |
|---|---|---|
| Medical Detox | 24/7 medically managed withdrawal | Anyone at risk of dangerous withdrawal |
| Residential / Inpatient | Live-in care, structured days, full therapy mix | Moderate-to-severe AUD, unstable home |
| Partial Hospitalization (PHP) | Day treatment, at least 20 hours a week, home at night | Needs structure, has stable housing |
| Intensive Outpatient (IOP) | At least 9 hours a week across several days | Stepping down, or balancing work and care |
| Outpatient / Aftercare | Weekly counseling, ongoing support | Mild AUD or maintaining recovery |
Detox is medically supervised withdrawal management. It clears alcohol from the body safely. It is not, on its own, treatment for the disorder, and that distinction matters more than almost anything else on this page. The NIDA is blunt about it: detox without follow-on care generally ends in a return to drinking, because detox addresses the body, not the patterns that drive the drinking.
Withdrawal can be dangerous. According to StatPearls, symptoms usually begin 6 to 24 hours after the last drink and are at their worst between 24 and 72 hours. The severe end of that range includes delirium tremens, a medical emergency. That’s why withdrawal for moderate-to-severe AUD belongs under medical supervision, where benzodiazepines and monitoring keep it safe. Once the physical danger has passed, the real work of behavioral treatment can begin, often in a residential setting.
Residential rehab means living at the treatment site, usually for 30 to 90 days, sometimes longer. The draw is total focus. No bar on the corner, no bottle in the cabinet, no 6 p.m. trigger waiting at home. Days are structured around individual therapy, group sessions, medical care, and time to rest.
It tends to suit people with moderate-to-severe AUD, co-occurring mental health conditions, or a home environment that makes staying sober nearly impossible. A typical day runs on a schedule: morning check-in, group therapy, an individual session, a wellness or skills block, an evening support meeting. The structure itself is part of how the treatment works. For many people, it’s the first stretch in years where the day isn’t organized around drinking.
Outpatient care lets a person live at home and keep working or caring for family while in treatment. The difference between the two main tiers is intensity. Intensive outpatient programs (IOP) run at least 9 hours a week, usually across three or more days, per the SAMHSA treatment guidance on the continuum of care. Standard outpatient is lighter, often a weekly counseling session or two.
IOP frequently works as a step-down after residential care or detox, easing the jump back into normal life without cutting support all at once. It also works as a starting point for people with mild-to-moderate AUD who have steady housing and a support system. You can hold a job and still be in real treatment. For a lot of people, that’s the difference between getting care and putting it off forever.
A PHP sits between residential care and IOP. It delivers day treatment, at least 20 hours a week by ASAM’s definition, then sends people home at night. The intensity is close to inpatient; the setting isn’t.
It’s a common step-down after a residential stay for someone who needs heavy structure but has a safe place to sleep. It’s also a step-up for an outpatient client who’s struggling and needs more than weekly sessions can give.
Virtual alcohol treatment is now mainstream, not a stopgap. Counseling, virtual IOP, and medication management all happen over video. The shift was fast: one national study in Drug and Alcohol Dependence found that the share of SUD treatment facilities offering telehealth jumped from 18% in 2019 to 79% by 2022.
The appeal is access. No commute, no waiting room, more privacy, and a way in for people in rural areas or with packed schedules. It isn’t right for everyone. Someone facing dangerous withdrawal needs in-person medical care first. But for ongoing counseling and maintenance, the research shows virtual care can hold its own.
Not sure which level of care fits? Reach Recovere is a nonprofit that helps you find treatment and find ways to pay for it. The search is free and confidential.
Find Treatment Near YouThree medications are FDA-approved to treat alcohol use disorder: naltrexone, acamprosate, and disulfiram. They work best alongside counseling, which is why clinicians group them under medication-assisted treatment. And they are dramatically underused.
How underused? NIAAA’s analysis of the 2024 NSDUH found that only 2.4% of adults with AUD, about 665,000 people, received any medication for it in the past year. A 2023 review in JAMA reached the same conclusion from the clinical side: oral naltrexone and acamprosate have solid evidence behind them, yet a fraction of eligible patients ever get a prescription. A NIAAA-funded researcher put the awareness gap plainly in a 2024 piece titled around the fact that effective AUD medications exist but few people have heard of them.
None of these is a standalone fix. The choice among them depends on a person’s goals, their health, and where they are in recovery.
| Medication | How It Works | Key Notes |
|---|---|---|
| Naltrexone (oral; Vivitrol injection) |
Blocks the rewarding effects of alcohol and reduces craving | Not for current opioid users; needs an opioid-free interval first |
| Acamprosate (Campral) |
Helps stabilize brain chemistry after drinking stops | Started once abstinent; taken three times daily; dose adjusts for kidney function |
| Disulfiram (Antabuse) |
Causes an unpleasant reaction if alcohol is consumed | A deterrent; needs commitment and often supervised dosing |
Naltrexone is an opioid antagonist. In plain terms, it dampens the reward and the craving that make drinking hard to stop, according to the FDA label on DailyMed. It comes two ways: a daily oral tablet, or Vivitrol, an extended-release shot given once every four weeks.
The two forms differ on one practical point. Oral naltrexone can be started while a person is still drinking, which lowers the bar to getting going. Vivitrol requires that a person not be actively drinking at the first injection. Both share a hard safety rule from the Vivitrol label: anyone using opioids has to be opioid-free for 7 to 10 days first, or the drug can trigger sudden, severe withdrawal. It tends to suit a motivated person who isn’t using opioids and wants help quieting cravings.
Acamprosate helps the brain settle after a person stops drinking. Heavy long-term alcohol use throws the brain’s chemistry off balance; acamprosate works on that imbalance to make abstinence easier to maintain. The FDA label is specific about timing: it’s for maintaining abstinence in people who are already abstinent when they start.
The dosing is two tablets, three times a day. That’s a lot of pills, and it asks something of a person’s routine. The dose also drops for anyone with reduced kidney function, and the drug isn’t used at all in severe kidney impairment. It fits someone who has finished detox, is committed to staying sober, and wants medication to help maintain that.
Disulfiram is a deterrent. Drink while taking it and you get sick, fast. It blocks an enzyme the body uses to break alcohol down, so a toxic byproduct builds up in the blood, per its FDA label. The reaction starts within about 10 to 30 minutes of drinking: flushing, a pounding head, nausea, vomiting, a racing heart.
That’s the whole mechanism. It doesn’t touch craving. It raises the stakes of a single drink, which only helps a person who’s genuinely committed to abstinence, often with someone supervising the daily dose. A person has to be sober before starting it. For the right candidate, the certainty of a bad reaction is exactly the deterrent they’ve been missing.
Two other medications come up often, used off-label. Topiramate and gabapentin aren’t FDA-approved for AUD, but the VA/DoD clinical guideline still recommends or suggests them, with topiramate carrying stronger support. These are prescriber decisions, weighed case by case.
GLP-1 medications, the class behind some diabetes and weight drugs, have drawn interest after reports of people losing the urge to drink. The evidence there is early and investigational. Worth watching, not yet worth counting on.
Counseling is the central part of alcohol treatment. Medication can quiet a craving, but it can’t teach a person what to do at 7 p.m. on a Friday when the craving hits anyway. That’s the work of behavioral therapy, and it pairs naturally with everything else. A realistic plan might combine CBT, naltrexone, and a weekly support group, each doing a different job.
A handful of approaches have the most research behind them, named directly in NIAAA’s core resource on treatment options:
A CBT session might map the exact chain that ends in a drink, the trigger, the thought, the urge, the action, and rehearse a different response at each link. Not abstract. Specific to the life the person actually lives.
Alcohol problems rarely travel alone. Depression, anxiety, trauma, and other conditions often sit underneath the drinking, and treating one while ignoring the other tends to fail. Integrated treatment, sometimes called dual-diagnosis care, addresses both at once. For someone whose drinking is tangled up with untreated anxiety, that combined approach is often the only one that holds.
Holistic add-ons, things like exercise, nutrition, mindfulness, and sleep, support recovery rather than replace medical care. They help a person rebuild a life that doesn’t revolve around alcohol. Useful alongside evidence-based treatment, not instead of it.
Peer support is free, available almost everywhere, and backed by better evidence than its critics assume. A 2020 Cochrane review found that Alcoholics Anonymous, delivered through 12-step facilitation, performed at least as well as other treatments like CBT for keeping people abstinent. In one analysis, 42% of AA participants stayed completely abstinent at one year, against 35% in other treatments.
AA isn’t the only model. SMART Recovery is a secular, science-based alternative built on cognitive behavioral principles, for people the spiritual framing of AA doesn’t reach. NIAAA notes that secular groups appear comparable to 12-step programs in effectiveness. The groups complement clinical care; they don’t replace medication or therapy. They’re the ongoing thread, the thing a person keeps doing after the formal program ends.
Fear of the unknown keeps a lot of people out of treatment, so it helps to know how the process actually unfolds.
It opens with intake and assessment. A clinician reviews drinking history, physical and mental health, and home situation, then builds a plan and recommends a level of care. If withdrawal is a risk, medical detox comes next, supervised and supported. From there a person enters the body of treatment, residential or outpatient, where the days fill with therapy.
A typical treatment day in a structured program looks something like this:
Family often gets pulled in through education or therapy sessions, because the people around a person shape recovery as much as the program does. Near the end, discharge planning maps out what comes after: outpatient care, a support group, medication, the aftercare that turns a good month into a durable recovery. The first day is the hardest part for most people. After that, the structure starts doing the work.
The right program is the one that matches the person, not the one with the nicest website. Two things drive the match: the level of care the assessment points to, and the fit with a person’s actual life, work, family, finances, and what they need to feel safe enough to stay. A working parent with moderate AUD might do best in an evening IOP paired with medication. Someone with severe AUD and an unstable home may need residential care to get a foothold at all.
A few things are worth weighing before committing to a program:
The NIAAA’s Alcohol Treatment Navigator lays out what higher-quality care looks like. Use it as a checklist:
If a program won’t answer direct questions about accreditation, staff credentials, or what its treatment actually involves, that’s an answer in itself.
Yes. AUD is manageable, and people recover every day. Recovery often isn’t a straight line, though, and the field has stopped pretending otherwise. The National Institute on Drug Abuse (NIDA) puts relapse rates for substance use disorders at 40% to 60%, on par with other chronic illnesses like hypertension and asthma, which run higher still.
That comparison reframes the whole question. Nobody calls insulin a failure when a person with diabetes has a bad stretch. NIDA treats a return to drinking the same way: a signal to resume or adjust treatment, not proof that treatment failed. Outcomes improve with longer engagement and real aftercare. The people who do best are usually the ones who stay connected to support after the formal program ends.
It’s common to return to drinking after a period of sobriety, and it doesn’t mean a person has failed. Clinicians treat it as a normal hurdle in managing a chronic condition, and as a useful piece of information. Most of the time it points to a trigger that didn’t get addressed, a support that fell away, or a plan that needs adjusting.
Which is why relapse-prevention planning is part of good treatment from the start. Spotting high-risk situations early. Knowing the warning signs. Having a concrete step to take and a person to call before a craving becomes a drink. The plan is what turns a slip into a course correction instead of a spiral.
Cost is the reason a lot of people never call. It shouldn’t be, and the law is more on your side than most people realize. Under the Affordable Care Act, substance use disorder treatment is one of the ten essential health benefits insurers must cover. The Mental Health Parity and Addiction Equity Act goes further, requiring that coverage for addiction and mental health be comparable to coverage for any other medical condition, as the Centers for Medicare & Medicaid Services explains.
Cost still varies a lot by level of care. Detox and residential treatment run higher than outpatient. But “I can’t afford it” is rarely the end of the conversation, because options exist on both sides of the insurance line.
Start by checking your benefits. Call the number on your insurance card, or have a treatment program verify coverage for you, which most will do at no cost. Ask three things: what levels of care are covered, which providers are in-network, and whether anything needs pre-authorization. Parity law means an insurer generally can’t impose harsher limits on addiction treatment than it does on other medical care. If a claim gets denied, that protection is worth pushing on.
No insurance doesn’t mean no treatment. Sliding-scale fees, payment plans, scholarships, and state-funded programs all exist for exactly this. SAMHSA funds free and low-cost options, and its FindTreatment.gov locator filters for them. The work is in finding the match, which is the gap a treatment directory is built to close.
Watching someone you love drink themselves into trouble is its own kind of hard. The instinct swings between rescuing and giving up, and neither helps much. What does help is steady, informed support, the kind that points toward treatment without taking over.
Support and enabling aren’t the same thing, and the line between them is where most families struggle. Covering for someone, paying off the consequences, smoothing things over, all of it can quietly keep the drinking going. Setting honest limits while staying connected is harder and more useful. MedlinePlus recommends groups like Al-Anon, where family members learn from others who’ve been exactly where they are.
Timing and tone carry the conversation. Pick a moment when the person is sober and things are calm, not mid-argument or mid-drink. Lead with what you’ve seen and how it affects you, not with accusation. Telling someone you’ve noticed more drinking and that you’re worried lands differently than telling them they have a problem.
Expect resistance; it’s normal, not a dead end. You don’t have to win the whole argument in one sitting. Sometimes the most useful thing is to come with a concrete option already in hand, a program, a number, a name, so that if the door opens even a crack, the next step is right there. When the situation is severe or stuck, a professional interventionist can help. So can SAMHSA’s free, confidential National Helpline at 1-800-662-HELP (4357).
Ready to look at real options? Reach Recovere helps you find treatment that fits your life and your budget, and figure out how to pay for it. Your search is free and confidential.
Search the Reach Recovere DirectoryThere’s no single best treatment. The strongest results usually come from combining approaches: FDA-approved medication, behavioral therapy like CBT, and ongoing peer support. The right mix depends on how severe the disorder is and what fits a person’s life. The NIAAA frames treatment around those three options for that reason.
Often, yes. Many people with mild-to-moderate AUD recover through outpatient counseling, medication prescribed by a doctor, and support groups, without ever entering a residential program. Severe AUD, especially with a risk of dangerous withdrawal, usually needs medical detox and a more intensive level of care first.
It depends on the level of care. Residential programs commonly run 30, 60, or 90 days. Outpatient care can last months, with support continuing well beyond that. Recovery itself is ongoing; the formal program is a starting point, not a finish line.
Three are FDA-approved: naltrexone, acamprosate, and disulfiram. Naltrexone reduces craving and reward, acamprosate helps maintain abstinence after a person stops, and disulfiram causes an unpleasant reaction if alcohol is consumed. Topiramate and gabapentin are sometimes prescribed off-label. All work best alongside counseling.
In most cases, yes. The Affordable Care Act counts addiction treatment as an essential health benefit, and federal parity law requires coverage comparable to other medical care. Coverage details vary by plan, so verify your specific benefits. If you don’t have insurance, sliding-scale fees, payment plans, and state-funded programs are available.
No. The NIDA puts relapse rates for substance use disorders at 40% to 60%, similar to other chronic conditions like hypertension and asthma. A return to drinking is treated as a signal to resume or adjust treatment, not as failure. It usually points to a trigger or support that needs attention.
The first day is mostly intake and assessment. A clinician reviews your drinking history, health, and circumstances, then builds a treatment plan and recommends a level of care. If withdrawal is a risk, medically supervised detox begins. It’s evaluation and stabilization, not therapy from minute one.
Knowing the options is one thing. Finding the right program near you is the next, and it’s where Reach Recovere comes in. As a nonprofit, Reach Recovere helps people find treatment and find ways to pay for it, without the sales pressure of a for-profit referral line. The directory lets you search by location and filter for the level of care you need.
The SAMHSA locator at FindTreatment.gov is a solid free backup, especially for state-funded and low-cost programs. Whichever door you use, the next step is small: one search, no commitment.
I am a professional writer, mainly in the fields of mental health, addiction, and living in recovery. I attempt to stay on top of the latest news in the addiction and the mental health world and enjoy writing about these topics to break the stigma associated with them.
If you or a loved one needs financial help for rehab, we’re here to support you.